Shannon Gwin Mitchell, Ph.D.

Shannon Gwin Mitchell, Ph.D.
Shannon Gwin Mitchell, Ph.D.
Senior Research Scientist

Ph.D., Human Services Psychology, University of Maryland, Baltimore County
M.A., Clinical Psychology, University of South Dakota
smitchell@friendsresearch.org
Phone: 410-837-3977 ext. 238
Fax: 410-752-4218
Research Interests

Dr. Mitchell is a Community Psychologist specializing in health services research. As a Senior Research Scientist at Friends Research Institute her work focuses not just on individuals, but the systems in which they work and live, and how those systems impact individual and organizational functioning. Dr. Mitchell has participated as a lead or co-investigator on numerous clinical trials addressing treatments for opioid use disorder (Extended Release Naltrexone for Youth [PI Mitchell]; Methadone Treatment Entry and Engagement [PI Schwartz]; IOP vs. OP with Buprenorphine for African Americans [PI Mitchell]; Reengineering Methadone Treatment [PI Schwartz]) as well as issues associated with treatment entry for people involved with the criminal justice system (Interim Methadone and Patient Navigation Initiated in Jail [PI Schwartz]; CJ-DATS MATICCE study [PI Friedmann]). She has also collaborated on several studies examining the use and implementation of Screening, Brief Intervention, and Referral to Treatment (SBIRT) in rural and urban community health centers as well as within schools (Adolescent SBIRT Implementation in an Urban FQHC [PI Mitchell]; SBIRT in New Mexico [PI Schwartz]; SBIRT Services in School-Based Health Centers [PI Gryczynski]).

Dr. Mitchell is a member of the College on Problems of Drug Dependence, the American Public Health Association, and the Society for Community Research and Action (Division 27 of APA) and serves as a reviewer for numerous national and international journals. Prior to joining Friends, Dr. Mitchell conducted qualitative research and worked on several projects at the Johns Hopkins University Bloomberg School of Public Health (projects INSPIRE, SHIELD, and STEP [PI Latkin]). Dr. Mitchell has authored or co-authored over 70 peer-reviewed publications.

Selected Publications
Gordon MS, Mitchell SG, Blue TR, Vocci FJ, Fishman MJ, Murphy SM, Couvillion K, Maher K, Ryan D, Wenzel K, Danner ML, Jarvis DK (in press). A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail. Journal of Substance Abuse Treatment
Lounsbury DW, Mitchell SG, Dusek K, Li Z, Kirk AS, Oros M, Hosler C, Schwartz RP, Gryczynski J, Monico LB & Brown BS (in press). Application of System Dynamics Modeling to Inform Implementation of Adolescent SBIRT in Primary Care Settings Journal of Behavioral Health Services & Research
Mitchell MM, Gryczynski J, Mitchell SG, Kelly SM, O’Grady KE, Monico LB, Schwartz RP (in press). A Latent Class Analysis of HIV Risk Factors Among Men and Women with Opioid Use Disorder in Pre-trial Detention AIDS and Behavior 2019 Nov 20. doi: 10.1007/s10461-019-02726-y. [Epub ahead of print] PMID: 31748939.
Mitchell SG, Nordeck CD, Lertch E, Ross TE, Welsh C, Schwartz RP, Gryczynski J (in press). Patients with substance use disorders receiving continued care in skilled nursing facilities following hospitalization Substance Abuse
Monico L, Ludwig A, Lertch E, Dionne R, Fishman M, Schwartz R, Mitchell S (in press). Adolescent and young adult opioid overdose experiences and their nuanced relationship with behavior change. Addiction
Monico L, Ludwig A, Lertch E, Mitchell S (in press). Using timeline methodology to visualize treatment trajectories of youth and young adults following inpatient opioid treatment. International Journal of Qualitative Methods
Schwartz RP, Mitchell MM, O’Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Gordon MS, Jaffe JH (in press). Pharmacotherapy for Opioid Addiction in Community Corrections International Review of Psychiatry 2018 Dec 6:1-19. doi: 10.1080/09540261.2018.1524373. [Epub ahead of print] PMID: 30522370.
Barbosa‐Leiker C, Campbell AN, Pavlicova M, Scodes J, Burlew AK, Hatch‐Maillette M, Mennenga SE, Mitchell SG, Novo P, Nunes EV (2020). Substance use and mental health in emerging adult vs older adult men and women with opioid use disorder. The American Journal on Addictions 29(6),536-542.
Carswell SB, Mitchell SG, Gryczynski J, Lertch E (2020). Computerizing NIAAA’s best practices for youth screening and brief intervention: A proof-of-concept pilot study of an automated alcohol screening and intervention resource tool. Journal of Drug Education 49(1-2), 3–14.
Gordon MS, Mitchell SG, Blue TR, Vocci FJ, Fishman MJ, Murphy SM, CouvillionK, Maher K, Ryan D, Wenzel K, Danner ML, Jarvis DK (2020). A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail. Journal of Substance Abuse Treatment 108241.
Gryczynski J, Nordeck CD, Martin RD, Welsh C, Schwartz RP, Mitchell SG, Jaffe JH (2020). Leveraging health information exchange for clinical research: Extreme underreporting of hospital service utilization among patients with substance use disorders. Drug and Alcohol Dependence ,107992.
Kelly SM, Schwartz RP, O’Grady KE, Mitchell SG, Duren T, Sharma A, Jaffe JH (2020). Impact of methadone treatment initiated in jail on subsequent arrest. Journal of Substance Abuse Treatment 113, 108006.
Lounsbury DW, Mitchell SG, Dusek KA, Li JZ, Kirk AS, Oros M, Hosler C, Schwartz RP, Gryczynski J, Monico LB, Brown BS (2020). Application of system dynamics to inform a model of adolescent SBIRT implementation in primary care settings. The Journal of Behavioral Health Services & Research 47(2), 230–244.
Mitchell MM, Gryczynski J, Mitchell SG, Kelly SM, O’Grady KE, Monico LB, Schwartz RP (2020). A latent class analysis of HIV risk factors among men and women with opioid use disorder in pre-trial detention. AIDS and Behavior 24(6), 1776–1783.
Mitchell SG, Gryczynski J, Schwartz RP, Kirk AS, Dusek K, Oros M, Hosler C, O’Grady KE, Brown BS (2020). Adolescent SBIRT implementation: Generalist vs. Specialist models of service delivery in primary care. Journal of Substance Abuse Treatment 111, 67-72.
Monico LB, Ludwig A, Lertch E, Dionne R, Fishman M, Schwartz RP, Mitchell SG (2020). Opioid overdose experiences in a sample of US adolescents and young adults: A thematic analysis. Addiction.
Monico LB, Ludwig A, Lertch E, Mitchell SG (2020). Using timeline methodology to visualize treatment trajectories of youth and young adults following inpatient opioid treatment. International Journal of Qualitative Methods 19, 1609406920970106.
Monico LB, Oros M, Smith S, Mitchell SG, Gryczynski J, Schwartz R (2020). One million screened: Scaling up SBIRT and buprenorphine treatment in hospital emergency departments across Maryland. The American Journal of Emergency Medicine 38(7), 1466-1469.
Nordeck CD, Welsh C, Schwartz RP, Mitchell SG, O’Grady KE, Dunlap L, Zarkin G, Orme S, Gryczynski J (2020). Navigation Services to Avoid Rehospitalization among Medical/Surgical Patients with Comorbid Substance Use Disorder: Rationale and Design of a Randomized Controlled Trial Journal of Psychiatry and Brain Science
Schwartz RP, Kelly SM, Mitchell SG, O’Grady KE, Sharma A, Jaffe JH (2020). Methadone treatment of arrestees: A randomized clinical trial Drug and Alcohol Dependence 107680.
Zarkin GA, Orme S, Dunlap LJ, Kelly SM, Mitchell SG, O’Grady KE, Schwartz RP (2020). Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail. Drug & Alcohol Dependence 217, 108292.
Gryczynski J, Mitchell SG, Schwartz RP, Kelly SM, Dušek K, Monico L, O’Grady KE, Brown BS, Oros M, Hosler C (2019). Disclosure of Adolescent Substance Use in Primary Care: Comparison of Routine Clinical Screening and Anonymous Research Interviews Journal of Adolescent Health 64(4):541-543. doi: 10.1016/j.jadohealth.2018.10.009. Epub 2018 Dec 18. PMID: 30578116.
Gryczynski J, Nichols H, Schwartz RP, Mitchell SG, Hill P, Wireman K (2019). Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder Drug and Alcohol Dependence 204:107515. doi: 10.1016/j.drugalcdep.2019.06.017. PMID: 31525569.
Monico LB, Mitchell SG, Dusek K, Gryczynski J, Schwartz RP, Oros M, Hosler C, O’Grady KE, Brown BS (2019). A Comparison of Screening Practices for Adolescents in Primary Care After Implementation of Screening, Brief Intervention, and Referral to Treatment. Journal of Adolescent Health Journal of Adolescent Health 65(1):46-50. doi: 10.1016/j.jadohealth.2018.12.005. Epub 2019 Mar 6. PMID: 30850312.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Jaffe JH (2019). Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrests Journal of Substance Abuse Treatment 97:7-13. doi: 10.1016/j.jsat.2018.11.006. Epub 2018 Nov 19. PMID:30577902.
Barbosa C, Wedehase B, Dunlap L, Mitchell SG, Dusek K, Schwartz RP, Gryzcynski J, Kirk AS, Oros M, Hosler C, O’Grady KE, Brown BS (2018). Start-Up Costs of SBIRT Implementation for Adolescents in Urban U.S. Federally Qualified Health Centers Journal of Studies on Alcohol and Drugs 79(3):447-454. PMID:29885153.
Dunlap LJ, Zarkin GA, Orme S, Meinhofer A, Kelly SM, O’Grady KE, Gryczynski J, Mitchell SG, Schwartz RP (2018). Re-engineering methadone-Cost-effectiveness analysis of a patient-centered approach to methadone treatment Journal of Substance Abuse Treatment 94:81-90. doi: 10.1016/j.jsat.2018.07.014. Epub 2018 Jul 31. PMID: 30243422.
Gryczynski J, Carswell SB, O’Grady KE, Mitchell SG, Schwartz RP (2018). Gender and ethnic differences in primary care patients’ response to computerized vs. in-person brief intervention for illicit drug misuse. Journal of Substance Abuse Treatment 84:50-56. doi: 10.1016/j.jsat.2017.10.009. Epub 2017 Nov 7. PMID: 29195593.
Mitchell SG, Gryczynski J, Schwartz RP (2018). Commentary on “The More Things Change: Buprenorphine/Naloxone Diversion Continues While Treatment is Inaccessible” Journal of Addiction Medicine 12(6):424-425. doi: 10.1097/ADM.0000000000000437. PMID:30095564.
Mitchell SG, Monico LB, Lertch E, Kelly SM, Gryczynski J, Jaffe J, O’Grady KE, & Schwartz RP (2018). Counseling staff’s views of patient-centered methadone treatment: Changing program rules and staff roles The Journal of Behavioral Health Services and Research 45(3):506-515. doi: 10.1007/s11414-018-9603-1. PMID: 29536342.
Mitchell SG, Monico LB, Stitzer M, Matheson T, Sorensen JL, Feaster DJ, Schwartz RP, Metsch L (2018). How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment. Journal of Substance Abuse Treatment 94:18-23. doi: 10.1016/j.jsat.2018.07.009. Epub 2018 Jul 22. PMID: 30243412.
Monico LB, Gryczynski J, Schwartz RP, Jaffe JH, O’Grady KE, & Mitchell SG (2018). Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12-months. The American Journal of Drug and Alcohol Abuse 44(6):604-610. doi: 10.1080/00952990.2018.1461877. Epub 2018 May 2. PMID: 29718715.
Monico LB, Mitchell SG (2018). Patient perspectives on transitioning from prescription opioids to heroin and the role of route of administration Substance Abuse Treatment, Prevention, and Policy 13(1):4. doi: 10.1186/s13011-017-0137-y. PMID: 29378623.
Nordeck CD, Welsh C, Schwartz RP, Mitchell SG, Cohen A, O’Grady KE, Gryczynski J (2018). Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation liaison service Drug and Alcohol Dependence
Schwartz RP, Mitchell MM, O’Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Gordon MS, Jaffe JH (2018). Pharmacotherapy for opioid addiction in community corrections International Review of Psychiatry 30(5):117-135. doi: 10.1080/09540261.2018.1524373. Epub 2018 Dec 6. PMID: 30522370.
Gryczynski J, McNeely J, Wu LT, Subramaniam G, Svikis D, Cathers L, Sharma G, King J, Jelstrom E, Nordeck CD, Sharma A, Mitchell S, O’Grady KE, Schwartz RP (2017). Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care Journal of General Internal Medicine 32(9), 990-996.
Gryczynski J, Nordeck CD, Mitchell SG, Page K, Johnsen L, O’Grady KE, Schwartz RP (2017). Pilot Studies of Substance Use Disorders (SUD) Prevalence and SUD Treatment Linkage at Urban Sexually Transmitted Disease (STD) Clinics Journal of Addiction Medicine 11(5), 350-356.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Gandhi D, Olsen Y, Jaffe JH (2017). Patient‐centered methadone treatment: a randomized clinical trial Addiction 112(3):454-64.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Jaffe JH (2017). When does methadone treatment reduce arrest and severity of arrest charges? An analysis of arrest records Drug and Alcohol Dependence 180:385-390. doi: 10.1016/j.drugalcdep.2017.08.025. Epub 2017 Sep 14. PMID: 28961545.
Schwartz RP, McNeely J, Wu LT, Sharma G, Wahle A, Cushing C, Nordeck CD, Sharma A, O’Grady KE, Gryczynski J, Mitchell SG, Ali RL, Marsden J, Subramaniam GA (2017). Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST Journal of Substance Abuse Treatment 76, 69-76.
Sharma A, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Schwartz RP (2017). Update on Barriers to Pharmacotherapy for Opioid Use Disorders Current Psychiatry Reports 19(6):35. doi: 10.1007/s11920-017-0783-9. Review. PMID: 28526967.
Chandler RK, Finger MS, Farabee D, Schwartz RP, Condon T, Dunlap LJ, Zarkin GA, McCollister K, McDonald RD, Laska E, Bennett D, Kelly SM, Hillhouse M, Mitchell SG, O’Grady KE, Lee J (2016). The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings. Contemporary Clinical Trials 48:166-72. doi: 10.1016/j.cct.2016.05.003. PMID: 27180088.
Gryczynski J, O’Grady KE, Mitchell SG, Ondersma SJ, Schwartz RP (2016). Immediate Versus Delayed Computerized Brief Intervention for Illicit Drug Misuse Journal of Addiction Medicine 10(5):344-51. doi: 10.1097/ADM.0000000000000248. PMID: 27504925.
Gryczynski J, Schwartz RP, O’Grady KE, Restivo LL, Mitchell SG, Jaffe JH (2016). Understanding patterns of high-cost health care use across different substance user groups Health Affairs (Millwood). 35(1):12-9. doi: 10.1377/hlthaff.2015.0618. PMID: 26733696 PMCID: PMC4936480 DOI: 10.1377/hlthaff.2015.0618.
Hong YA, Mitchell SG, Peterson JA, Latkin C, Tobin K (2016). Ethnographic process evaluation. Monitoring and Evaluation in Health and Social Development: Interpretive and Ethnographic Perspectives 159.
Mitchell SG, Willett J, Monico LB, James A, Rudes DS, Viglioni J, Schwartz RP, Gordon MS, Friedmann PD (2016). Community Correctional Agents’ Views of Medication-Assisted Treatment: Examining their Influence on Treatment Referrals and Community Supervision Practices. Substance Abuse 37(1):127-33. doi: 10.1080/08897077.2015.1129389. PMID: 26860334. PMCID: PMC4823810.
Monico LB, Mitchell SG, Welsh W, Link N, Hamilton L, Malvini Redden S, Schwartz R, & Friedmann P (2016). Developing effective interorganizational relationships between community corrections and community treatment providers. Journal of Offender Rehabilitation
Monico LB, Schwartz RP, Gryczynski J, O’Grady KE, & Mitchell SG (2016). Two models of integrating buprenorphine treatment and medical staff within formerly “drug-free” outpatient programs Journal of Psychoactive Drugs
Ondersma SJ, Gryczynski J, Mitchell SG, O’Grady KE, Schwartz RP (2016). Process evaluation of a technology-delivered screening and brief intervention for substance use in primary care. Internet Interventions. 4(Pt 1):11-16. PMID: 27110494PMCID: PMC4836054. DOI: 10.1016/j.invent.2016.01.004.
Schwartz RP, Kelly SM, Mitchell SG, Dunlap L, Zarkin GA, Sharma A, O’Grady KE, Jaffe JH (2016). Corrigendum to “Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial” Contemporary Clinical Trials 51:97. doi: 10.1016/j.cct.2016.09.008. PMID: 27729206.
Schwartz RP, Kelly SM, Mitchell SG, Dunlap L, Zarkin GA, Sharma A, O’Grady KE, Jaffe JH (2016). Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial. Contemporary Clinical Trials 49:21-8. doi: 10.1016/j.cct.2016.06.002. PMID: 27282117.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Gandhi D, Olsen Y, Jaffe JH (2016). Patient-centered methadone treatment: a randomized clinical trial. Addiction doi: 10.1111/add.13622. [Epub ahead of print]. PMID: 27661788.
Sharma A, O’Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Schwartz RP (2016). Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Substance Abuse and Rehabilitation 7:27-40. doi: 10.2147/SAR.S81602. Review. PMID: 27217808. PMCID: PMC4853155 DOI: 10.2147/SAR.S81602.
Barbosa C, Dunlap LJ, Wedehase B, Mitchell SG, Schwartz RP, Dušek K, Kirk AS, Oros M, Hosler C, Gryczynski J, Brown BS (2015). Start-up costs of implementing Screening and Brief Intervention (SBI) for Adolescents (part of Economics of SBI symposium) Addiction Science and Clinical Practice 10 (Suppl 2), O5.
Gryczynski J, Kelly SM, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2015). Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients Addiction.  110(2):240-7. doi: 10.1111/add.12767. Epub 2014 Nov 20. PMID: 25311148.
Gryczynski J, Mitchell SG, Gonzales A, Moseley A, Peterson TR, Ondersma SJ, O’Grady KE, Schwartz RP (2015). A randomized trial of computerized vs. in-person brief intervention for illicit drug use in primary care: outcomes through 12 months.  Journal of Substance Abuse Treatment 50, 3-10. doi: 10.1016/j.jsat.2014.09.002. Epub 2014 Sep 16. PMID: 25282578.
Gryczynski J, Mitchell SG, Jaffe JH, O’Grady KE, Olsen YK, Schwartz RP (2015). Leaving buprenorphine treatment: patients’ reasons for cessation of care Journal of Substance Abuse Treatment 46(3):356-61. PubMed PMID: 24238714; PubMed Central PMCID: PMC3947058.
Gryczynski J, Mitchell SG, Ondersma SJ, O’Grady KE, Schwartz RP (2015). Potential radiating effects of misusing substances among medical patients receiving brief intervention Journal of Substance Abuse Treatment 55:39-44.
Gryczynski J, Nordeck CD, Mitchell SG, O’Grady KE, McNeely J, Wu LT, Schwartz RP (2015). Reference periods in retrospective behavioral self-report: A qualitative investigation American Journal on Addictions 24(8), 744-747.
Gryczynski J, Schwartz RP, Mitchell SG, Dzirasa L, Dušek K, O’Grady K, and Cowell A (2015). Preliminary research in preparation for a randomized trial of brief intervention strategies for adolescents in school-based health centers Addiction Science and Clinical Practice 10 (Suppl 2), O20. http://doi.org/10.1186/1940-0640-10-S2-O20.
Mitchell SG, Gryczynski J, Schwartz RP, Myers CP, O’Grady KE, Olsen YK, Jaffe JH (2015). Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use. Journal of Psychoactive Drugs 47(2):149-57.
Mitchell SG, Monico LB, Gryczynski J, O’Grady KE, Schwartz RP (2015). Staff Views of Acceptability and Appropriateness of a Computer-Delivered Brief Intervention for Moderate Drug and Alcohol Use. Journal of Psychoactive Drugs 47(4):301-7. doi: 10.1080/02791072.2015.1075631. Epub 2015 Sep 16. PMID: 26375411.
Mitchell SG, Schwartz RP, Alvanzo AA, Weisman MS, Kyle TL, Turrigiano EM, Gibson ML, Perez L, McClure EA, Clingerman S, Froias A, Shandera DR, Walker R, Babcock DL, Bailey GL, Miele GM, Kunkel LE, Norton M, Stitzer ML (2015). The Use of Technology in Participant Tracking and Study Retention: Lessons Learned from a Clinical Trials Network Study. Substance Abuse 36(4):420-6. doi: 10.1080/08897077.2014.992565. Epub 2015 Feb 11. PMID: 25671593. PMCID: PMC4532645.
Mitchell SG, Willett J, Swan H, Monico LB, Yang Y, Patterson Y, Belenko S, Vega-Debien Graciela Pankow J, Schwartz RP and Visher C (2015). Defining success: Insights from a random assignment, multi-site study of implementing HIV prevention, testing and linkage to care in US jails and prisons. AIDS Education and Prevention 27(5):432-45. doi: 10.1521/aeap.2015.27.5.432. PMID: 26485233.
Monico LB, Gryczynski J, Mitchell SG, Schwartz RP, O’Grady KE, Jaffe JH (2015). Buprenorphine treatment and 12-step meeting attendance: conflicts, compatibilities, and patient outcomes. Journal of Substance Abuse Treatment   57:89-95. doi: 10.1016/j.jsat.2015.05.005. Epub 2015 May 12. PMID: 25986647.
Monico LB, Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH (2015). Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention. Journal of Substance Abuse Treatment 57:57-62. doi: 10.1016/j.jsat.2015.04.010. Epub 2015 May 7. PMID: 25980599.
Schwartz RP, Kelly SM, Gryczynski J, Mitchell SG, O’Grady KE, Jaffe JH (2015). Heroin use, HIV-risk, and criminal behavior in Baltimore: Findings from Clinical Research. Journal of Addictive Diseases 34(2-3):151-61. doi: 10.1080/10550887.2015.1059222. PMID: 26079104.
Visher CA, Yang Y, Mitchell SG, Patterson Y, Swan H, Pankow J (2015). Understanding the Sustainability of Implementing HIV Services in Criminal Justice Settings Health & Justice 3(5).
Gryczynski J, Schwartz RP, Mitchell SG, O’Grady KE, Ondersma SJ (2014). Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use Drug and Alcohol Dependence 141:44-50. doi: 10.1016/j.drugalcdep.2014.05.001. Epub 2014 May 17. PMID: 24932945. PMCID: PMC4080811.
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2014). Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients.  Drug and Alcohol Dependence 140:213-6. PubMed PMID: 24793367; PubMed Central PMCID: PMC4070874.
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2014). Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use.  Pediatrics 133(5):819-26. PubMed PMID: 24753528; PubMed Central PMCID: PMC4006430.
Mitchell SG, Gryczynski J, Kelly SM, O’Grady KE, Jaffe JH, Olsen YK, Schwartz RP (2014). Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status Journal of Drug Issues 44(1):69-82. PMID:25364037.
Mitchell SG, Kelly SM, Gryczynski J, Myers CP, O’Grady KE, Kirk AS, Schwartz RP (2014). The CRAFFT Cut-Points and DSM-5 Criteria for Alcohol and Other Drugs: A Reevaluation and Reexamination Substance Abuse 35(4):376-80. PubMed PMID: 25036144; PubMed Central PMCID: PMC4268117.
Müller-Leonhardt A, Mitchell SG, Vogt J, Schürmann T (2014). Critical Incident Stress Management (CISM) in complex systems: cultural adaptation and safety impacts in healthcare Accident Analysis and Prevention 68:172-80. PubMed PMID: 24491831.
Schwartz RP, Gryczynski J, Mitchell SG, Gonzales A, Moseley A, Peterson TR, Ondersma SJ, O’Grady KE (2014). Computerized versus in-person brief intervention for drug misuse: a randomized clinical trial Addiction 109(7):1091-8. doi: 10.1111/add.12502. Epub 2014 Mar 10. PMID: 24520906. PMCID: PMC4086904.
Teruya C, Schwartz RP, Mitchell SG, Hasson AL, Thomas C, Buoncristiani SH, Hser Y-I, Wiest K, Cohen AJ, Glick N, Jacobs P, McLaughlin P, Ling W (2014). Patient perspectives on buprenorphine/naloxone: A qualitative study of retention during the Starting Treatment with Agonist Replacement Therapies (START) study Journal of Psychoactive Drugs 46(5):412-26. doi: 10.1080/02791072.2014.921743. PMID: 25364994.
Friedmann PD, Ducharme LJ, Welsh W, Frisman L, Knight K, Kinlock T, Mitchell SG, Hall E, Urbine T, Gordon MS, Abdel-Salam S, O’Connell D, Albizu-Garcia C, Knudsen H, Duval J, Fenster J; Jennifer Pankow for the CJ-DATS MATICCE Workgroup (2013). A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol Health Justice 19; 1(6). doi: 10.1186/2194-7899-1-6. PMID: 25309847. PMCID: PMC4193542.
Gryczynski J, Jaffe JH, Schwartz RP, Dušek KA, Gugsa N, Monroe CL, O’Grady KE, Olsen YK, Mitchell SG (2013). Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.  American Journal on Addictions 22(3):285-91.
Gryczynski J, Mitchell SG, Jaffe JH, Kelly SM, Myers CP, O’Grady KE, Olsen YK, Schwartz RP (2013). Retention in methadone and buprenorphine treatment among African Americans.  Journal of Substance Abuse Treatment 45(3):287-92.
Mitchell SG, Gryczynski J, O’Grady KE, Schwartz RP (2013). SBIRT for adolescent drug and alcohol use: current status and future directions Journal of Substance Abuse Treatment 44 (5), 463-472.
Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH (2013). A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans Drug and Alcohol Dependence 128 (3), 222-229.
Schwartz RP, Gryczynski J, O’Grady KE, Sharfstein JM, Warren G, Olsen Y, Mitchell SG, Jaffe JH (2013). Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009 American Journal of Public Health  103(5):917-22.
Schwartz RP, Gryczynski J, O’Grady KE, Sharfstein JM, Warren G, Olsen YK, Mitchell SG, Jaffe JH (2013). Schwartz et al. respond.  American Journal of Public Health 2013 103(8):e2-3..Epub 2013 Jun 13.
Gonzales A, Westerberg VS, Peterson TR, Moseley A, Gryczynski J, Mitchell SG, Buff G, Schwartz RP (2012). Implementing a statewide Screening, Brief Intervention, and Referral to Treatment (SBIRT) service in rural health settings: New Mexico SBIRT Substance Abuse 33 (2), 114-123. [PMCID: PMC3325793].
Kelly SM, Brown BS, Katz EC, O’Grady KE, Mitchell SG, King S, Schwartz RP (2012). A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients The American Journal of Drug and Alcohol Abuse 38 (3), 233-238.
Mitchell SG, Gryczynski J, Peterson T, Gonzales A, Moseley A, Schwartz RP (2012). Screening, Brief Intervention, and Referral to Treatment (SBIRT) for substance use in a school-based program: Services and outcomes American Journal on Addictions 21 S5-S13.
Mitchell SG, Kelly SM, Brown BS, O’Grady KE, Schwartz RP (2012). HIV sex-risk behaviors among in- versus out-of-treatment heroin-addicted adults American Journal of Drug and Alcohol Abuse 38 (4), 328-333.
Mitchell SG, Kelly SM, Gryczynski J, Myers CP, Jaffe JH, O’Grady KE, Olson YK, Schwartz RP (2012). African-American patients seeking treatment in the public sector: Characteristics of buprenorphine v. methadone patients Drug and Alcohol Dependence 122, 55-60. [PMCID: PMC3251709].
Gryczynski J, Mitchell SG, Peterson TR, Gonzales A, Moseley A, Schwartz RP (2011). The relationship between services delivered and substance use outcomes in New Mexico’s Screening, Brief Intervention, Referral and Treatment (SBIRT) Initiative Drug and Alcohol Dependence 118 (2-3), 152-157. [PMCID: PMC21482039].
Gryczynski J, Schwartz RP, Salkever DS, Mitchell SG, Jaffe JH (2011). Patterns in admission delays to outpatient methadone treatment in the United States Journal of Substance Abuse Treatment 41 (4), 431-439. [PMCID: PMC3205308].
Kelly SM, O’Grady KE, Mitchell SG, Brown BS, Schwartz RP (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis.  Drug and Alcohol Dependence 117. (2-3), 170-175. [PMCID: PMC3148301].
Mitchell SG, Morioka R, Reisinger HS, Peterson JA, Kelly SM, Agar MH, Schwartz RP, et al (2011). Redefining retention: recovery from the patient’s perspective Journal of Psychoactive Drugs 43 (2), 99-107. [PMCID: PMC3160714].
Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Brown BS (2011). Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts Drug and Alcohol Dependence 115 (1-2), 23-29. [PMCID: PMC3059350].
Schwartz RP, Mitchell SG, Gordon MS, and Kinlock TW (2011). Pharmocotherapy. In C. Leukefeld, J. Gregrich & T. P. Gullotta (Eds.),  Handbook on Evidence-Based Substance Abuse Treatment Practice in Criminal Justice Settings, Issues in Childrens’ and Families’ Lives 11  (pp. 259-277). New York: Springer Publishing.
Della LJ, DeJoy DM, Mitchell SG, Goetzel RZ, Chung-Roemer E, Wilson MG (2010). Management support and workplace health promotion: Field test of the Leading by Example (LBE) assessment tool American Journal of Health Promotion 25 (2), 138-146.
Kelly SM, O’Grady KE, Brown BS, Mitchell SG, Schwartz RP (2010). The role of patient satisfaction in methadone treatment.  American Journal of Drug and Alcohol Abuse, 36 (3), 150-154. [PMCID: PMC2938880].
Mitchell SG, Lounsbury D (2010). Community Psychology. In C. S. Clauss-Ehlers (Ed.) Encyclopedia of Cross-Cultural School Psychology  (pp. 249-256). New York, NY: Springer.
Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O’Grady KE, Brown BS, Agar MH (2010). Why don’t out-of-treatment individuals enter methadone treatment programs? International Journal of Drug Policy 21 36-42. [PMCID: PMC2790538].
Frye V, Fortin P, MacKenzie S, Purcell D, Edwards LV, Mitchell SG, Valverde E, Garfein RS, Metsch L, Latka MH (2009). Managing identity impacts associated with disclosure of HIV status: A qualitative investigation AIDS Care 21(8), 1071-1078.
Kelly SM, Schwartz RP, O’Grady KE, Mitchell SG, Reisinger HS, Peterson JA, Agar MH, Brown BS (2009). Gender differences among in- and out-of-treatment opioid-addicted individuals.  American Journal of Drug and Alcohol Abuse 35, 38-42.
Lounsbury DW Mitchell SG (2009). Introduction to special issue on social ecological approaches to community health research and action American Journal of Community Psychology 44(3/4), 213-220. doi: 10.1007/s10464-009-9266-4. PMID: 19777338.
Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, O’Grady KE Schwartz RP (2009). Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.  The American Journal on Addictions
Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, Schwartz RP (2009). Incarceration and opioid withdrawal: The experiences of methadone patients and out-of-treatment heroin users.  Journal of Psychoactive Drugs
Mitchell SG, Goetzel RZ, Ozminkowski RJ (2008). The value of worksite health promotion. ACSM’s Heath and Fitness Journal 12(2), 23-27.
Peterson JP, Schacht-Reisinger H, Schwartz RP, Mitchell SG, Kelly SM, Brown BS, Agar MH (2008). Targeted sampling in drug abuse research: A review and case study.  Field Methods 20(2), 155-170.
Reisinger HS, Schwartz RP, Mitchell SG, Peterson JA, Kelly SM, O’Grady KE, Marrari EA, Brown BS, Agar MH (2008). Premature discharge from methadone treatment: Patient perspectives Journal of Psychoactive Drugs
Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Peterson JA, Reisinger HS, Agar MH, Brown BS (2008). Attitudes toward buprenorphine and methadone among opioid-dependent individuals. American Journal on Addictions 17(5), 396-401.
Schwartz RP, Kelly SM, O’Grady KE, Peterson JA, Reisinger HS, Mitchell SG, Wilson ME, Agar MH, Brown BS (2008). In-treatment v. out-of-treatment opioid dependent adults: Drug use and criminal history. American Journal of Drug and Alcohol Abuse 34(1), 17-28.
Lounsbury D Mitchell SG (2007). Introduction: Special Issue on Community Health and Community Health Research The Community Psychologist
Mitchell SG, Edwards LV, Mackenzie S, Knowlton A, Valverde E, Arnsten J, Santibanez S, Latka MH, and Mizuno Y (2007). Participants’ descriptions of social support within a multi-site intervention for HIV-seropositive injection drug users (INSPIRE Journal of Acquired Immune Deficiency Syndromes 46(Suppl. 2), S55-S63. doi: 10.1097/QAI.0b013e3181576808. PMID: 18089985.
Mitchell SG, Mitchell JT (2006). Caplan, community, and critical incident stress management International Journal of Emergency Mental Health 8(1), 5-14. PMID: 16573248.
Mitchell SG, Peterson JA and Latkin CA (2006). The impact of drug use on perceptions of credibility in indigenous outreach workers Qualitative Health Research 16, 1108-1119, PMID: 16954528.
Peterson JA, Mitchell SG, Hong Y, Agar MH and Latkin CA (2006). Getting clean and harm reduction: Adversarial or complimentary issues for injection drug users Cadernos de Saude Publica, 22(4), 733-740, ISSN 0102-311X, Epub 2006 Apr 5, PMID: 16612427
Antonellis PJ Mitchell SG (2005). Posttraumatic Stress Disorder in Firefighters: The Calls that Stick with You Ellicott City, MD: Chevron Publishing
Hong Y, Mitchell SG, Peterson JA, Latkin CA, Tobin K and Gann D (2005). Ethnographic process evaluation: Piloting an HIV prevention intervention program among injection drug users International Journal of Qualitative Methods 4(1), Article.
Mitchell SG (2005). Developing our emergency mental health research capacity: Taming the chaos in a multidisciplinary field International Journal of Emergency Mental Health 7(1), 1-4, PMID: 15869075.
Peterson JA, Mitchell SG, and Latkin CA (2005). The shooting gallery: Opportunities and implications for the introduction of an ethnographic HIV prevention intervention AIDS Anthropology Bulletin 17 (2), 26-28.
Mitchell SG, and Loomis C (2000). Faculty-graduate student mentoring: A community psychology perspective The Community Psychologist 33(4), 19-20.